Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 50.73

-2.8%

3:19 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Londo who wrote (6893)	8/13/2002 12:22:10 PM
From: Ian@SI	Read Replies (3) of 52153

[ot] economy stuff... And if this does work - we see large magnitudes of inflationary growth. Take your pick. With capacity utilization near a multi-decade low at about 76%, the odds of inflation are substantially reduced. Any company attempting to raise prices will simply lose market share. Similarly until capacity utilization gets back to the mid or upper 80s, lowering rates will have only a marginal affect on stimulating CapEx growth. Supporting innovation could cause some companies to junk old capacity and replace it with new, improved capacity. But lower rates alone aren't enough. Government policies which stimulate consumer demand will help. e.g. - getting the long term rates down could stimulate housing growth.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next